Johnson & Johnson (JNJ) Tuesday reported a profit for the first-quarter rose 6.9 percent from last year, reflecting continued recovery in medical devices and strength in its pharmaceutical business. Quarterly sales rose 7.9 percent. Both adjusted earnings per share and quarterly revenues topped analysts' expectations.
Looking ahead for fiscal year 2021, the company now expects adjusted earnings per share to be in the range of $9.42 - $9.57, compared to the prior estimation of $9.40 - $9.60. Analysts expect annual earnings of $9.50 per share.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.